Targeting Rac1 signaling inhibits streptococcal M1 protein-induced CXC chemokine formation, neutrophil infiltration and lung injury.
Infections with Streptococcus pyogenes exhibit a wide spectrum of infections ranging from mild pharyngitis to severe Streptococcal toxic shock syndrome (STSS). The M1 serotype of Streptococcus pyogenes is most commonly associated with STSS. In the present study, we hypothesized that Rac1 signaling might regulate M1 protein-induced lung injury. We studied the effect of a Rac1 inhibitor (NSC23766) on M1 protein-provoked pulmonary injury. Male C57BL/6 mice received NSC23766 prior to M1 protein challenge. Bronchoalveolar fluid and lung tissue were harvested for quantification of neutrophil recruitment, edema and CXC chemokine formation. Neutrophil expression of Mac-1 was quantified by use of flow cytometry. Quantitative RT-PCR was used to determine gene expression of CXC chemokines in alveolar macrophages. Treatment with NSC23766 decreased M1 protein-induced neutrophil infiltration, edema formation and tissue injury in the lung. M1 protein challenge markedly enhanced Mac-1 expression on neutrophils and CXC chemokine levels in the lung. Inhibition of Rac1 activity had no effect on M1 protein-induced expression of Mac-1 on neutrophils. However, Rac1 inhibition markedly decreased M1 protein-evoked formation of CXC chemokines in the lung. Moreover, NSC23766 completely inhibited M1 protein-provoked gene expression of CXC chemokines in alveolar macrophages. We conclude that these novel results suggest that Rac1 signaling is a significant regulator of neutrophil infiltration and CXC chemokine production in the lung. Thus, targeting Rac1 activity might be a potent strategy to attenuate streptococcal M1 protein-triggered acute lung damage.
Department of Clinical Sciences, Section for Surgery, Lund University, Malmö, Sweden.
Songen
S
Zhang
Milladur
M
Rahman
Su
S
Zhang
Lei
L
Song
Heiko
H
Herwald
Henrik
H
Thorlacius
D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D002460:Cell Line; D019743:Chemokines, CXC / Q000096:biosynthesis*; D004195:Disease Models, Animal; D015870:Gene Expression; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D055370:Lung Injury / Q000235:genetics / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology; D016676:Macrophages, Alveolar / Q000276:immunology* / Q000378:metabolism*; D008297:Male; D051379:Mice; D020556:Neutrophil Infiltration / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology / Q000473:pathology; D011654:Pulmonary Edema / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction; D013297:Streptococcus pyogenes / Q000276:immunology; D020830:rac1 GTP-Binding Protein / Q000235:genetics / Q000378:metabolism*
D000634:Aminoquinolines; D000942:Antigens, Bacterial; D019743:Chemokines, CXC; C487513:NSC 23766; D011743:Pyrimidines; D020830:rac1 GTP-Binding Protein